This is a serious, avoidable problem. We know how much excess mortality there was leading up to October last year, even if we were greatly under-reporting deaths and hospitalizations. Delaying rollout by 6 weeks compared to U.S. had serious consequences last year. We should have adapted this year based on this knowledge, especially since infections, hospitalizations and deaths this year are similar to or higher than last year. Are StatsCan excess mortality data not shared with decision makers to ensure they're properly informed? The gap between reality and what's detected/reported is a chasm now. Are there no policy makers who have looked at excess mortality data, or paused and worried about the consequences of these delays and restriction of vaccine access?